ReviewJournal of cardiovascular pharmacology2017

Targeting β3-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade.

Alessandro Cannavo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.